Devon Medical launches Cirona 6300 portable DVT prevention therapy device

25 October 2015 (Last Updated October 25th, 2015 18:30)

Devon Medical Products, a US-based medical device designer and manufacturer, has introduced the Cirona 6300 portable deep vein thrombosis (DVT) prevention therapy device.

Devon Medical Products, a US-based medical device designer and manufacturer, has introduced the Cirona 6300 portable deep vein thrombosis (DVT) prevention therapy device.

The system features an adjustable sleeve with a compression therapy device unit attached and it can be used at home or in a hospital to assist in the prevention of DVT and improve circulation, which could help diminish post-operative pain and swelling.

DVT is a condition in which blood clots (thrombus) in a vein deep inside a muscle in the body. It is commonly found in the deep veins of the pelvis, thigh or calf.

This condition can partly or completely block blood flow, resulting in sudden swelling, pain or a sensation of warmth.

Cirona 6300 simulates blood flow in extreme conditions by using pneumatic compression and helps to avoid the early onset of blood clots that can occur following various traumas or in post-operative settings.

Adjustable velcro sleeves make it easy in applying and removing the device for therapy.

"The Cirona 6300 brings convenience and clinical efficacy to this important prevention therapy."

Devon Medical president Chip Ross said: "As a company dedicated to improving patients' lives, we are excited to add this product to our family of Cirona DVT devices, which are already used in hospitals worldwide.

"The American Hospital Association estimates that 1 out of every 1,000 Americans develops DVT each year.

"The Cirona 6300 brings convenience and clinical efficacy to this important prevention therapy."

The company noted users should press and hold the start button to start therapy with the treatment, which can be halted and started at any time.

The Cirona 6300 device features rechargeable batteries that can last for eight hours.

Ross said: "As the patient population at risk for post-operative DVT increases, we believe this product provides a complete solution in preventing this serious condition.

"The product's best-in-class battery life and simple design will enhance patient compliance, the goal of all post-operative care."

Approximately 300,000 people die each year from DVT-related pulmonary embolisms in the US.